Company intelligence / Profile preview

CircleDNA

Hong Kong, Hong Kong

Ownership: Private
Employees: ~500
Development stage: Other

Overview

CircleDNA offers consumer-grade, clinical-quality DNA testing based on Whole Exome Sequencing, providing over 500 reports on disease risk, nutrition, fitness, carrier status and medication response. Data is returned to users via digital dashboard with professional genetic counseling included. The company claims >99.9% analytical accuracy and supports ongoing updates to user reports as scientific knowledge evolves[2][3][4][5][6].

Therapeutic areas: CardiovascularNeurologyMetabolic DisordersRare DiseasesOtherOncology
Modalities: Molecular diagnostics
Industry: Molecular Diagnostics

Partnerships

Berry Genomics

Beyond the preview

Go deeper on CircleDNA.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on CircleDNA.

Explore the full profile